The Cancer Treatment Research Foundation
The Cancer Treatment Research Foundation
The Cancer Treatment Research Foundation (CTRF, Web site: www.ctrf.org) is a non-profit national medical research organization dedicated to expediting the translation of research findings directly into treatment options for cancer patients. CTRF’s mission is to raise, manage, and distribute resources for innovative cancer research and educational programs. CTRF is the beneficiary of generous corporate underwriting, including Cancer Treatment Centers of America, which underwrites the entire administrative and most of the fund raising expenses. CTRF’s primary consideration in granting support is the immediacy of improvement in treatment options and quality of life for cancer patients. CTRF seeks to fund progressive clinical approaches that may stand alone or complement conventional treatments. CTRF is not a traditional source of funds and believes that many other resources are available for incremental improvements in cancer therapy. For example, CTRF will not support extensions of conventional or traditional chemotherapy such as phase III/IV trials. Also, while transitional research of a pre-clinical nature which is within a year of clinical trials will be considered, basic research will not be supported.
The overall goal of the Clinical Investigation Grant program of CTRF is to fund young investigators who are without support from the NIH or other cancer research agencies working on innovative research relevant to cancer therapy (e.g., new agents, immunotherapy, biological response modifiers, gene therapy), clinical nutrition, quality of life, and cancer education. Established clinical researchers who wish to embark on innovative studies with novel, new, or pilot projects may also apply and should demonstrate that their project is a departure from ongoing, funded work. Awarded funds may be used to support the proportion of salary devoted to the project by the principal investigator and other key personnel. Funds may be used for supplies and non-reimbursable research-related patient care costs, including extraordinary laboratory and imaging studies. Equipment will be funded only in extremely rare circumstances. The amount of the award varies with the availability of funds. Previous awards have ranged between $10,000 and $125,000/year. The maximum period of funding is for two years.
A Preliminary Grant Application may be downloaded at the CTRF Web site or obtained by calling (847) 342-6484.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.